CSIMarket
 


Qualigen Therapeutics Inc   (QLGN)
Other Ticker:  
 
 

QLGN's EPS Net Growth by Quarter and Year

Qualigen Therapeutics Inc 's EPS Net results by quarter and year




QLGN EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -0.17 -0.19 -0.41
III Quarter September -0.64 -0.10 -0.10 -2.12
II Quarter June -0.69 -0.11 -0.18 -0.05
I Quarter March -0.78 -0.12 -0.13 -0.04
FY   -2.11 -0.50 -0.60 -2.62



QLGN EPS Net third quarter 2023 Y/Y Growth Comment
Qualigen Therapeutics Inc in the third quarter 2023 recorded EPS net loss of $ -0.64 .

According to the results reported in the third quarter 2023, Qualigen Therapeutics Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Qualigen Therapeutics Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2023.




QLGN EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Qualigen Therapeutics Inc 's third quarter 2023 EPS Net $ -0.64 QLGN's Income Statement
Qualigen Therapeutics Inc 's third quarter 2022 EPS Net $ -0.10 Quarterly QLGN's Income Statement
New: More QLGN's historic EPS Net Growth >>


QLGN EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Qualigen Therapeutics Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QLGN's III. Quarter Q/Q EPS Net Comment
Although Qualigen Therapeutics Inc in the III. Quarter 2023 showed EPS net loss of $ -0.64 , it should be said, that those numbers are improvement compare to the -0.69 in the second quarter.

Within Major Pharmaceutical Preparations industry Qualigen Therapeutics Inc achieved highest sequential EPS Net growth. While Qualigen Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


QLGN's III. Quarter Q/Q EPS Net Comment
Even if Qualigen Therapeutics Inc in the III. Quarter 2023 admitted EPS net loss of $ -0.64 , management mentioned, that those numbers point to improvement compare to the -0.69 in the second quarter.

Within Major Pharmaceutical Preparations industry Qualigen Therapeutics Inc achieved highest sequential EPS Net growth. While Qualigen Therapeutics Inc 's EPS Net growth quarter on quarter, overall rank is .


Qualigen Therapeutics Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS Net 12 Months Ending $ -2.28 $ -1.74 $ -1.16 $ -0.50 $ -0.52
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Qualigen Therapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -2 in the Sep 30 2023 period.
The business is getting worse as the cumulative EPS net loss is becoming larger from $ -1.74 for the period from Jun 30 2023 to Sep 30 2022 and $ -0.52365302146193 for the twelve months ending in the quarter Sep 30 2022 Mónica Silva Cardoso mentioned.

Qualigen Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Qualigen Therapeutics Inc ' has realized cumulative trailing twelve months EPS net loss of $ -2 in the Sep 30 2023 period.
The results are getting worse as the cumulative EPS net loss is inflating from $ -1.74 in TTM ending quarter Jun 30 2023 and $ -0.52365302146193 from the TTM period ending Sep 30 2022.

Qualigen Therapeutics Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
QLGN's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for QLGN's Competitors
EPS Net Growth for Qualigen Therapeutics Inc 's Suppliers
EPS Net Growth for QLGN's Customers

You may also want to know
QLGN's Annual Growth Rates QLGN's Profitability Ratios QLGN's Asset Turnover Ratio QLGN's Dividend Growth
QLGN's Roe QLGN's Valuation Ratios QLGN's Financial Strength Ratios QLGN's Dividend Payout Ratio
QLGN's Roa QLGN's Inventory Turnover Ratio QLGN's Growth Rates QLGN's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2023
Anavex Life Sciences Corp 454.76%$ 454.755 
Privia Health Group Inc 400.00%$ 400.000 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com